You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Neuromonitoring of Traumatic Brain/blast Injury
SBC: EMPIRICAL TECHNOLOGIES CORPORATION Topic: OSD09H06The objective of the proposed program is the development of a mobile and non-invasive cerebro-physiological monitor that will permit the tracking of cerebral functions and the identification of developing pathologic brain conditions in wounded soldiers during transport and under medical care in forward areas. Specifically, the purpose of the system will be to continuously track cerebral blood flow ...
SBIR Phase II 2011 Department of DefenseDefense Health Agency -
Development of a Scalable and Extensible Enterprise Master Patient Index for the NHIN
SBC: SYSNET International, Inc. Topic: OSD09H12The problem of inaccurate patient identification due to errors introduced during data capture or due to syntactic and semantic differences between patient registration systems is one of the biggest challenges facing healthcare today. An inefficient and inaccurate master patient index introduces duplicate and/or overlaid patient records which can then cause inappropriate or delayed treatments, adve ...
SBIR Phase II 2011 Department of DefenseDefense Health Agency -
Technologies for Treating Cartilage Tissue Loss Following Traumatic Injury
SBC: Spheringenics, Inc. Topic: OSD10H04Phase I studies demonstrate that human adipose stem cells (ASCs) exhibit characteristics of chondrocytes when cultured in chondrogenic media (CM) and this is enhanced when they are first encapsulated in low viscosity, high mannuronate content alginate beads that are less than 200fYm in diameter containing 250 cells/bead. The microencapsulated cells express mRNAs for factors associated with chondr ...
SBIR Phase II 2012 Department of DefenseDefense Health Agency -
Advanced Blood Simulant for Simulation Based Medical Trauma Training
SBC: LUNA INNOVATIONS INCORPORATED Topic: OSD10H01The proposed Phase II program is designed to build upon the successes of the Phase I feasibility study and develop an advanced blood simulant for training of combat first responders in the use of modern hemostatic products. The blood simulant will exhibit a caking/clotting response in the presence of simulated hemostatic agents while accurately approximating the viscosity and color of human blood ...
SBIR Phase II 2012 Department of DefenseDefense Health Agency -
Chimeric Autologous/Allogeneic Constructs for Skin Regeneration
SBC: Stratatech Corporation Topic: OSD11H10Complex skin defects, including burns and trauma, represent a major medical problem affecting both military and civilian populations. In recent military engagements, burns account for approximately 5% of combat casualties. Furthermore, approximately 1.25 million Americans each year require medical attention for complex skin defects, with 50,000 people hospitalized for burns and 13,000 requiring sk ...
SBIR Phase II 2013 Department of DefenseDefense Health Agency -
Monitoring Metabolic Energy Expenditure Via the Prosthetics of Lower Extremity Amputees
SBC: BARRON ASSOCIATES, INC. Topic: OSD11H07Limb loss affects approximately 1.9 million people in the United States. It is well established that lower-limb amputees show greater metabolic demands during gait and more limited mobility compared to non-disabled individuals. Currently, there is no lower-extremity prosthesis available that can monitor the metabolic costs of the amputee. The proposed solution, code-named TEQUILA (Total Energy exp ...
SBIR Phase II 2013 Department of DefenseDefense Health Agency -
A Nano-pharmaceutical Platform for Creating Artificial Vaccines
SBC: PARABON NANOLABS, INC. Topic: OSD11H01In this project, Parabon NanoLabs will employ its Essemblix(tm) Drug Development Platform, a combination of computer-aided design (CAD) software and DNA nano-fabrication technology, to produce artificial vaccines against the biothreat agent ricin on DNA origami decorated first with natural epitopes and ultimately with artificial epitotopes (hereafter"mimotope") constructed from a predefined set of ...
SBIR Phase II 2013 Department of DefenseDefense Health Agency -
Flying Insect Sampling Device (FISDe)
SBC: McQ Inc. Topic: DHP12007The Army Defense Health Program has a need for a novel freestanding device to sample and collect a broad spectrum of flying insects (order Diptera) for the purpose of analyzing possible disease vectors. The sampling device is required to be effective against mosquitoes (Anopheles, Aedes, and Culex) and sand flies (Phlebotomus and Lutzomyai) in particular, and with desired applicability to other sp ...
SBIR Phase II 2014 Department of DefenseDefense Health Agency -
Skin Substitute Technology for Chimeric Autologous/Allogeneic Constructs for Skin Regeneration- Preclinical Studies
SBC: Stratatech Corporation Topic: OSD11H10Complex skin defects, including burns and trauma, represent a major medical problem affecting both military and civilian populations. In recent military engagements, burns account for approximately 5% of combat casualties. Furthermore, approximately 1.25 million Americans each year require medical attention for complex skin defects, with 50,000 people hospitalized for burns and 13,000 requiring sk ...
SBIR Phase II 2015 Department of DefenseDefense Health Agency -
Technologies for Treating Cartilage Tissue Loss Following Traumatic Injury
SBC: Spheringenics, Inc. Topic: OSD10H04Traumatic injuries to the head and neck region comprise as much as 30 percent of all combat injuries observed today. These injuries often involve multiple tissues including dermal, muscle, cartilage and bone. This work aims to address this critical need by treating a composite tissue injury model in the ear. We will use an alginate microbead cell delivery system
SBIR Phase II 2015 Department of DefenseDefense Health Agency